// App-Quantinova.ai

4557 : A retrospective analysis of patients with poor-risk germ cell tumor (PRGCT) treated at Indiana University from 2000 to 2010.

Researchers

Presenter

  • Nabil Adra

Principal Investigators

  • Costantine Albany

  • Daniel Sonnenburg

  • Yan Tong

  • Nasser H. Hanna

  • Lawrence H. Einhorn

Medical Centers

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN

  • Melvin and Bren Simon Cancer Center at Indiana University, Indianapolis, IN

  • Indiana University, Indianapolis, IN

  • Indiana University School of Medicine, Indianapolis, IN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Testicular cancer

  • Germ cell tumor

  • Solid malignancies

Biomarkers

  • Alpha-fetoprotein

  • Chorionic Gonadotropin Subunit Beta 5

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved